Adenosine 5′-[β-thio]diphosphate trilithium salt

• Catalog No.: A8016
• CAS Number: 73536-95-5
• M. F.: C10H12Li3N5O9P2S
• M. W.: 461.065902
• Purity: ≥80% (HPLC)

SYNONYMS

• IUPAC name: trilithium(1+) ion ({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)(sulfanylidene)phosphonite
• IUPAC Traditional name: trilithium(1+) ion {[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy(sulfanylidene)phosphonite
• Synonyms: Adenosine-5′-0-(2-thiodiphosphate) trilithium salt; Ado-5′-PP[S]; ADP-β-S

DATABASE IDS

• MDL Number: MFCD00077314
• PubChem SID: 24891307
• CAS Number: 73536-95-5

PROPERTIES

• Empirical Formula (Hill Notation): C10H12Li3N5O9P2S
• Purity: ≥80% (HPLC)
• GHS Signal Word: Warning
• GHS Hazard statements: H302-H371
• European Hazard Symbols: Harmful (Xn)
• Personal Protective Equipment: dust mask type N95 (US), Eyeshields, Faceshields, Gloves
• GHS Precautionary statements: P260
• Risk Statements: 20/21/22-68/20/21/22
• Safety Statements: 36/37
• Storage Temperature: -20°C
• German water hazard class: 3

DETAILS

Description (简体中文)

Biochem/physiol Actions
P2Y receptor agonist.
Other Notes
Non-hydrolyzable ADP analog
Substrates
Substrate and inhibitor for AMP dependent enzyme systems.
Application
Adenosine 5′-[β-thio]diphosphate is a substrate and inhibitor for AMP dependent enzyme systems. Adenosine 5′-[β-thio]diphosphate has been used to explore the myenteric control mechanisms of human esophageal motility and the effect of nitrergic and nonnitrergic neurotransmitters.

Description (English)

Biochem/physiol Actions
P2Y receptor agonist.
Other Notes
Non-hydrolyzable ADP analog
Substrates
Substrate and inhibitor for AMP dependent enzyme systems.
Application
Adenosine 5′-[β-thio]diphosphate is a substrate and inhibitor for AMP dependent enzyme systems. Adenosine 5′-[β-thio]diphosphate has been used to explore the myenteric control mechanisms of human esophageal motility and the effect of nitrergic and nonnitrergic neurotransmitters.